RAKOVINA THERAPEUTICS
Rakovina Therapeutics’ focus is the development of new cancer treatments based on novel DNA-damage response technologies. The Company has established a pipeline of novel DNA-damage response inhibitors with the goal of advancing one or more drug candidates into human clinical trials and obtaining marketing approval for new cancer therapeutics from Health Canada, the United States Food and Drug Administration and similar international regulatory agencies
RAKOVINA THERAPEUTICS
Industry:
Biotechnology Life Science
Founded:
2020-01-01
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Website Url:
http://www.rakovinatherapeutics.com
Total Employee:
1+
Status:
Active
Total Funding:
9.13 M CAD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins Sitelinks Search Box IPv6
Similar Organizations
Aulos Bioscience
Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Current Employees Featured
Founder
Investors List
Red Thread Ventures
Red Thread Ventures investment in Series A - Rakovina Therapeutics
Official Site Inspections
http://www.rakovinatherapeutics.com Semrush global rank: 5.93 M Semrush visits lastest month: 1.39 K
- Host name: 172.67.143.99
- IP address: 172.67.143.99
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Rakovina Therapeutics"
Home - Rakovina Therapeutics
Unlocking New Frontiers in Cancer Treatment to Improve Patient Lives. At Rakovina Therapeutics, we’re wholly committed to pushing the boundaries of discovery and research …See details»
About - Rakovina Therapeutics
Rakovina Therapeutics is a biopharmaceutical research company focused on the development of innovative cancer treatments. Our work is based on unique technologies for targeting the DNA …See details»
Rakovina Therapeutics Presents AI-Driven Drug …
November 25, 2024, Vancouver, British Columbia – Rakovina Therapeutics Inc. (TSX-V: RKV) (“Rakovina” or the “Company”), a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage …See details»
Rakovina Therapeutics - LinkedIn
? Rakovina Therapeutics is using AI to revolutionize cancer treatment by accelerating the discovery of new drug candidates targeting DNA-damage response inhibitors (DDRi). ⚡ With a projected...See details»
Rakovina Therapeutics Inc., Author at Life Sciences British Columbia
Rakovina Therapeutics is a biopharmaceutical research company focused on the development of innovative cancer treatments. Our work is based on unique technologies for targeting the DNA …See details»
Rakovina Therapeutics - Crunchbase Company Profile & Funding
Publicly traded (RKV.V) company focused on the development of new cancer treatments based on novel DNA-damage response technologies. Rakovina Therapeutics announced the second …See details»
Rakovina Therapeutics Announces Strategic Pivot to AI - Yahoo …
Mar 27, 2024 · Founded in 2021, Rakovina’s mission has always been to transform and prolong the lives of individuals battling cancer. The DNA-damage response is a crucial mechanism for …See details»
Rakovina Therapeutics Presents AI-Driven Drug ... - Financial Post
3 days ago · Article content. VANCOUVER, British Columbia, Nov. 25, 2024 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (“Rakovina” or the “Company”), a …See details»
Rakovina Therapeutics Announces Private Placement Offering
May 24, 2024 · The Company has received initial commitments totaling over $800,000 from strategic investors in connection with the Offering. For Immediate Release Vancouver, British …See details»
Rakovina Therapeutics to Present at the AACR-NCI-EORTC
Aug 17, 2021 · Hosted by the American Association for Cancer Research (AACR), the National Cancer Institute (NCI), and the European Organisation for Research and Treatment of Cancer …See details»
Rakovina Therapeutics Receives Funding to Accelerate
Mar 22, 2023 · VANCOUVER, British Columbia, March 22, 2023 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV: RKV) (“the Company”), is pleased to announce that it is …See details»
Rakovina Therapeutics Presents AI-Driven Drug Discovery
3 days ago · Register for the webinar or access the live stream here: https: ... [email protected]. Investor Relations and Media: Susan Xu Investor Relations …See details»
Rakovina Therapeutics Announces Private Placement Offering
13 hours ago · David Hyman, Chief Financial Officer [email protected]. Invest Relations & Media Michelle Seltenrich [email protected] 778-773-5432See details»
Rakovina Therapeutics and Variational AI Announce Drug …
May 24, 2024 · September 17, 2024, Vancouver, British Columbia – Rakovina Therapeutics Inc. (TSX-V: RKV), a biopharmaceutical company committed to advancing new cancer therapies …See details»
Rakovina Therapeutics Announces Upcoming Poster Presentation …
Nov 20, 2024 · Rakovina Therapeutics is a biopharmaceutical research company focused on the development of innovative cancer treatments. Our work is based on unique technologies for …See details»
Rakovina Therapeutics Inc. Commences Trading on TSX Venture
Apr 1, 2021 · Rakovina Therapeutics will begin trading as a Tier 2 Issuer on the TSX Venture Exchange (" TSXV ") under the symbol " RKV ". About Rakovina Therapeutics Inc. Rakovina …See details»
Rakovina Therapeutics Announces Non-dilutive Financial …
Dec 21, 2021 · Funding from NRC IRAP will support the development of new research infrastructure for screening and optimization of potential drug candidates from Rakovina …See details»
Rakovina Therapeutics Announces Private Placement Offering
13 hours ago · David Hyman, Chief Financial Officer [email protected]. Invest Relations & Media Michelle Seltenrich [email protected] 778-773-5432 ...See details»
News & Media - Rakovina Therapeutics
Mar 27, 2024 · Press Releases & News Coverage.See details»
Careers - Rakovina Therapeutics
We work with determination, laugh a lot, and truly enjoy what we do. If you’re passionate about pursuing transformative cancer research, consider joining our team. Click or drag a file to this …See details»